![Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/dea6c9cc-a83e-4746-b803-cdf1d2bc61a1/trc212018-fig-0002-m.jpg)
Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
![Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-10322-9/MediaObjects/41598_2022_10322_Fig1_HTML.png)
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports
![A microRNA signature that correlates with cognition and is a target against cognitive decline | EMBO Molecular Medicine A microRNA signature that correlates with cognition and is a target against cognitive decline | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/46378117-f119-48b1-8a12-ee44a7b7834a/emmm202013659-fig-0001-m.jpg)
A microRNA signature that correlates with cognition and is a target against cognitive decline | EMBO Molecular Medicine
![Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-021-00470-z/MediaObjects/41746_2021_470_Fig1_HTML.png)
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
![Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression | Radiology: Artificial Intelligence Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression | Radiology: Artificial Intelligence](https://pubs.rsna.org/cms/10.1148/ryai.2021200171/asset/images/medium/ryai.2021200171.fig3.gif)
Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression | Radiology: Artificial Intelligence
![IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML](https://www.mdpi.com/ijms/ijms-20-04149/article_deploy/html/images/ijms-20-04149-ag.png)
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
![Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1568163721001082-ga1.jpg)
Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect
![Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12911-019-0974-x/MediaObjects/12911_2019_974_Fig1_HTML.png)
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text
![Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - ScienceDirect Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213858720301182-gr1.jpg)
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - ScienceDirect
![The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter](https://pbs.twimg.com/media/Fblx8iHXkAAEiwy.jpg)
The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter
![The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5b22281b-6eb3-4347-8130-875ae1a6f552/gr1_lrg.jpg)
The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics
![PDF) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease | Rosanna Squitti - Academia.edu PDF) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease | Rosanna Squitti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46079357/mini_magick20190210-25190-13269lj.png?1549835767)
PDF) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease | Rosanna Squitti - Academia.edu
![Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/5aa57542-eef9-4546-ba25-d352958b754d/gr1_lrg.jpg)
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology
![Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment - eBioMedicine Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment - eBioMedicine](https://www.thelancet.com/cms/attachment/d5855e57-3a41-4dce-b1aa-d5f4e0ec2dff/gr1_lrg.jpg)
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment - eBioMedicine
![Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/42/7/1362/F1.large.jpg)
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience
![DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease](https://www.jpreventionalzheimer.com/wp-content/uploads/2021/05/FIG-2-KNOX.gif)
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
![Frontiers | Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease Frontiers | Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease](https://www.frontiersin.org/files/MyHome%20Article%20Library/688478/688478_Thumb_400.jpg)